pharma · Asthma · Respiratory Syncytial Virus Infections
GSK Glaxo Smith
GlaxoSmithKline
NovaPharmaNews editorial coverage mentioning GSK Glaxo Smith — regulatory, clinical, and market analysis.
Company details
- Status
- Public
- HQ
- 637 r Aulnois, Saint Amand les Eaux, 59 59230, FR, SAINT-AMAND LES EAUX
- Employees
- 30
- Programs
- 205
- Drugs
- 194
- Patents
- 0
News & analysis
NovaPharmaNews articles mentioning GSK Glaxo Smith — regulatory, clinical, and market coverage.
NovaPharmaNews editorial coverage mentioning GSK Glaxo Smith — regulatory, clinical, and market analysis.
Friday Five: Key Regulatory Updates in Pharma
This article covers significant regulatory updates impacting the pharmaceutical industry, including GSK's breakthrough in hepatitis B and Eli Lilly's advancements in prevention.
GSK and Ionis Present Promising Hepatitis B Drug Data
GSK and Ionis have unveiled significant data on their hepatitis B drug, presenting a potential functional cure. This development could reshape treatment strategies in the pharmaceutical industry.
AbbVie and GSK's Rise in Patient Reputation: Insights for Pharma
AbbVie and GSK have made significant strides in patient reputation in the UK. This article explores the implications for the pharmaceutical industry.